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Abstract Treatment of yeast pbospboglycerate kinase (PGK) 
with trypsin results in a fourfold increase in the V,,,., of this 
enzyme, without affecting the Km. This activation is shown to be 
due to the removal of the C-terminal lysine residue. The C- 
terminal sequence folds back over the N-terminal domain and 
contacts the extreme N-terminal sequence which folds onto the 
C-terminal domain, thus making many of the inter-domain 
contacts in this two domain protein. Previous studies have shown 
that this C-terminal region is important in mediating the 
conformational changes required during catalysis by yeast 
PGK. Observation of the three-dimensional structure of this 
enzyme suggests that removal of the C-terminal lysbre residue 
will strengthen the interaction between K5 and K413. This 
indicates that this salt bridge stabilises the enzyme in the higher 
activity form, while the presence of K415 reduces the strength of 
that interaction. 
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1. Introduction 
Phosphoglycerate kinase (PGK) is a monomeric enzyme 
which catalyses the phosphorylation of 3-phosphoglycerate. 
The three-dimensional structures of this enzyme from horse 
muscle [l], yeast [2], pig muscle [3], and Bacillus stearothermo- 
philus [4] have been determined. In all these species the fold of 
the protein chain is very similar, and they all consist of two 
continuous structural domains of similar size. In the native 
fold of the enzyme inter-domain contacts are made through 
helix V, which links the two domains, and the C-terminal 
helices XIII and XIV, which contact the N-terminal domain. 
The two domains of PGK have been shown to be capable 
of folding independently into stable structural units [5-81. 
Further folding studies have shown that the C-terminal, do- 
main spanning helix XIV, although clearly involved in the 
inter-domain contacts, is not required for the structural integ- 
rity of either domain [9] but is important in stabilising their 
interactions across the waist region [lo]. 
Such studies have provided dynamic support for the early 
proposal that PGK, along with other kinases, undergoes a 
conformational change during catalysis [l]. Upon binding 
substrates the two domains of the protein are thought to 
change their relative positions, both bringing the two sub- 
strates together, and excluding water from the active site. 
NMR [l I], small angle X-ray scattering [12,13] and analytical 
ultracentrifugation [14] studies have been interpreted in terms 
of large conformational changes associated with hinge bend- 
ing. In such a mechanism the two domains rotate about their 
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interdomain contacts. Results from fluorescence anisotropy 
decay [15] suggest that this rotation is relatively small. 
A mutant protein lacking the 15 C-terminal residues (helix 
XIV and the preceding loop) has been expressed [16]. This 
protein, although able to bind substrates, exhibits only 0.1% 
of the catalytic activity of the native protein. This supports a 
hypothesis in which the C-terminal helix, although not in- 
volved in the folding or substrate binding of phosphoglycerate 
kinase, has a key role in mediating the conformational change 
required for catalysis. 
Here we report that removal of the C-terminal lysine resi- 
due, Lys-415, results in a large increase in the V,, of yeast 
phosphoglycerate kinase, while little or no change in the Km is 
observed. This gives further support to the permissive model 
of hinge bending previously proposed in which the energy 
barrier between the two conformers is relatively low, allowing 
the binding of substrate to swing the hinge to the active state 
[15,17]. 
2. Materials and methods 
Yeast phosphoglycerate kinase (EC 2.7.2.3) was obtained from Sig- 
ma Chemical Co., and was shown to run as a single band on electro- 
phoresis in the presence of SDS, and have similar kinetic properties to 
those reported for this enzyme [18]. Chicken muscle glyceraldehyde-3- 
phosphate dehydrogenase (EC 1.2.1.12), DPCC treated bovine type 
XI trypsin, ATP and 3-phosphoglycerate were also obtained from 
Sigma Chemical Co. The ODjm Aquapore ODS column was pur- 
chased from Brownlee, acetonitrile from Rathburn Chemicals Ltd 
and sodium I-octanesulfonate from Sigma Chemicals. Other chemi- 
cals were of analytical grade. 
2.1. Tryptic digestion 
Prior to treatment with trypsin, phosphoglycerate kinase was dis- 
solved in a minimal volume of 100 mM Tris, 10 mM CaCls (pH 8.0) 
and desalted into the same buffer using a PDlO column (Pharmacia) 
and diluted to a concentration of 4 mg/ml. The sample was then 
equilibrated at 37°C and digestion initiated by the addition of trypsin 
to a concentration of 10 &ml. 40 pl samples were taken at various 
times after the addition of trypsin, and the reaction was stopped by 
the addition of 1 ul 10 mM PMSF. 
Samples from the tryptic digests were analysed by electrophoresis in 
the presence of SDS on 12% polyacrylamide according to [19] and 
16.5% polyacrylamide according to [20]. 
2.2. Enzyme kinetics 
The specific activity of PGK was measured. in the absence of sul- 
phate, by a modification of a method of Scopes [21]. The assay mix- 
ture contained 10 mM Tris/HCl, pH 7.2, 5 mM magnesium chloride, 
15 mM 3-phosphoglycerate, 5 mM ATP, and 50 pg/ml rabbit muscle 
glyceraldehyde-3-phosphate dehydrogenase. Activity was measured by 
following the change in absorbance at 340 nm. All measurements were 
made at 25°C. 
K, values for wild-type and activated PGK were determined for 
both substrates in the presence of 50 mM sodium sulphate as de- 
scribed [18]. The assay solution contained 10 mM Tris/HCl, pH 7.2, 
50 mM sodium sulphate, 0.2 mM NADH, 150 ug/ml glyceraldehyde- 
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Table 1. Michaelis constants of both native and trypsin treated 
PGK for ATP and 3-phosphoglvcerate (3PG) 
3-phosphate dehydrogenase and either 5 mM ATP or 5 mM 3-phos- 
phoglycerate. The concentration of the second substrate was then 
varied over a range from 0.03 to 5 mM, and the concentration of 
free magnesium kept to 1 mM. Activity at 25°C was measured by 
following the change in absorbance at 340 nm. 
2.3. N-terminal sequencing 
200 pmol of PGK sample to be sequenced was spotted onto PVDF 
paper. The samples were then subject to automated Edman sequen- 
cing using a Beckman LF 3000. 
2.4. Lysine determination 
Samples were analysed for free lysine by a modification of the 
method of Scalia et al. [22]. An ABI Model 172 Series HPLC system 
was used to analyse samples on a 4.6 mm internal diameter 100 mm 
ODSoo aquapore Cl8 column with 300 A pore size and 7 firn spherical 
packing. Lysine standards were prepared by dissolving iysine in 100 
mM Tris. 10 mM CaCI? CaH 8.0) and mixine them 1: 1 with HPLC 
buffer (26 mM sodium phisphate’buffer (pH16.5):acetonitrile (85:15, 
v/v) containing 0.01 M sodium I-octanesulphonate), and filtering 
through a 0.22 km filter. Samples for analysis were diluted I:1 in 
HPLC buffer and filtered through a 0.22 km filter. 40 ~1 were loaded 
on to the column, and eluted isocratically with HPLC buffer (filtered 
through a 0.45 km filter) at 0.2 ml/min at ambient temperature. The 
eluent was monitored for absorbance at 210 nm. 
3. Results 
3.1. Limited treatment with trypsin results in an activation of 
PGK 
When yeast phosphoglycerate kinase at 4 mg/ml in 100 mM 
Tris, 10 mM CaClz pH 8.0 is treated with trypsin at 0.01 mg/ 
ml, at 37”C, there is a marked increase in the PGK activity in 
the forward direction, under saturating substrate conditions. 
This increase in the specific activity occurs over 20 min and 
goes to four times the initial activity (Fig. 1). At later times 
there is a fall in the activity as the protein is further digested. 
3.2. There is no accompanying change in the apparent 
molecular mass 
When samples from the trypsin digest are subjected to elec- 
trophoresis in 12% acrylamide gels in the presence of SDS, 
there is no apparent change in the migration of the protein. 
This suggests that the activation of the protein is due to the 
removal of either a small peptide or a single amino acid from 
either the N- or C-terminus of the protein. Analysis of the 
same samples on 16.5% acrylamide gels, which normally vi- 
sualise peptides as small as 2.5 kDa [20], showed no evidence 
for any peptide of this size or above being liberated. 
Both native and activated PGK were subjected to N-term- 
inal sequence analysis. When we attempted to sequence 200 
pmol of native PGK, no sequence was obtained. This is con- 
sistent with previous reports that the N-terminal serine of this 
protein is acetylated [23]. When a sample of PGK, mixed first 
with PMSF and then trypsin (zero time of digestion), was 
subjected to sequencing, the only sequence obtained was 
that of trypsin, and that just at the limit of detection (1 
pmol). When a sample treated with trypsin for 20 min was 
sequenced, in addition to the trypsin sequence, the following 
amino acids were detected at less than 5 pmol: position 1 - A, 
Y, and T; position 2 - H, R, and L; position 3 ~ T and E; 
position 4 - D, P, and N; position 5 - A, and K; position 6 - 
E; and position 7 - G, and P. 
3.3. Lysine is released concurrently with the activation 
Samples from the tryptic digest of yeast phosphoglycerate 
Km (ATPI 
(mM) 
K,,, (3-PG) 
(mM) 
Specific activity 
Wmg) 
Native 0.32 0.43 850 
Activated 0.41 0.55 3250 
K,,, values and specific activities were determined as described (Sher- 
man et al. [18]) except that for specific activity measurements, ATP 
and 3-PG were present at 5 mM and 15 mM respectively. Native and 
activated refers to phosphoglycerate kinase untreated and treated with 
trypsin for 20 min respectively, as described in the text. 
kinase were analysed by HPLC for the presence of free lysine 
[22]. This method proved to be highly sensitive, and able to 
quantify as little as 20 ng of free lysine. There is a release of 
lysine during the treatment of yeast PGK with trypsin, occur- 
ring over the first 20 min (Fig. 1). After 20 min of digestion, 
which gives the maximal activation, the molar free lysine con- 
centration is 70% of the total PGK concentration. However, 
at the same time as the removal of Lys-415, digestion will 
occur at other sites, resulting in inactivation. Because of 
this, the maximal activity observed is lower than that of 
100% de-Lys-415 PGK. The kinetics of release of lysine are 
seen to parallel those of activation. This suggests that the 
observed activation of the protein is due to the release of a 
single lysine from the C-terminus yeast PGK. 
3.4. There is no change in the K, 
The effect of trypsin treatment on the Michaelis constants 
for ATP and 3-phosphoglycerate of yeast PGK was deter- 
mined (Table 1). On digestion with trypsin for 20 min there 
is a fourfold increase in activity but only a marginally signifi- 
cant increase in K,,,. The K,,, of the native protein is consistent 
with published data [18]. 
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Fig. 1. The activation of, and release of free lysine from, yeast 
phosphoglycerate kinase (PGK) by trypsin. PGK at 4 mg/ml in 100 
mM Tris, 10 mM CaCl2 was incubated at 37°C with trypsin at 10 
pg/ml. Samples were take at various times and the trypsin inacti- 
vated with PMSF. Samples were assayed for PGK activity by the 
method of Scopes [21], and the activity normalised to the activity of 
untreated PGK. Free lysine was determined by the method of Scalia 
and Massaccesi [22]. 
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Fig. 2. The structure of the hinTge region of yeast phosphoglycerate kinase. Based on molecular coordinates from the crystal structure of Wat- 
son et al. [2], displayed on the QUANTA molecular graphics package. Glutamate-413 is in yellow and lysine-415 (to the right of glutamate- 
413) and lysine-5 (to the left of glutamate-413) are in red; other residues are in pink. 
4. Discussion 
Treatment of yeast PGK with trypsin results in a dramatic 
increase in its specific activity. That there is no accompanying 
change in the mobility of this enzyme on polyacrylamide gel 
electrophoresis shows that trypsin is not removing more that a 
short peptide from either the C- or N-terminal end of the 
protein. Inspection of the primary sequence of yeast PGK 
[2] shows that likely peptides to be released are a pentapeptide 
from the N-terminus, a 12 amino acid peptide from the C- 
terminus, or a single C-terminal lysine. In the light of the 
results of Ritco-Vonsovici et al. [lo] it is highly improbable 
that removal of the C-terminal 12 amino acids is involved. 
They showed that a truncated protein lacking these 12 amino 
acids, although able to fold, exhibits only 0.1% of the activity 
of the wild-type enzyme. 
Attempts to detect any peptide using the gel system of 
Schagger and Vonjagow [20], designed to visualise small pep- 
tides, showed no evidence for the release of any larger pep- 
tides during the activation of PGK by trypsin. When either 
native or activated phosphoglycerate kinase was subjected to 
N-terminal sequence analysis, no clear sequence was obtained. 
The trace residues detected on sequencing reflect the gradual 
digestion of PGK in regions not including the N- or C-termi- 
ni. Clearly no peptide has been removed from the N-terminus. 
If a peptide had been hydrolysed from the C-terminus, then 
the sequence of this peptide should have been detected. It is 
concluded that the activation of yeast PGK is not caused by 
the cleavage of a peptide from either terminus of PGK. The 
only other possible cause for the tryptic activation of yeast 
PGK is the removal of the C-terminal lysine residue. 
An HPLC method [22] was used to detect free lysine. This 
showed that during the tryptic activation of PGK 1 mol of 
lysine was liberated per mol of PGK. This leads to the con- 
clusion that the activation is caused by the removal of the C- 
terminal lysine. 
Upon activation of PGK there is no significant effect on the 
K, for either substrate. This is not surprising as in the three- 
dimensional structure lysine-415 is well separated from either 
substrate binding site [2]. It is therefore improbable that the 
activation of PGK by trypsin is mediated by a change in the 
immediate conformation of the substrate binding sites. 
The C-terminal helix is important in the interaction between 
the two domains. In the crystal structure [2] it folds over the 
N-terminal domain. Truncated PGK, lacking the 15 C-term- 
inal amino acids, has been characterised [lo]. This protein, 
although able to fold to a native-like structure and bind sub- 
strates, exhibits only 0.1% of the catalytic activity of the wild- 
type enzyme. This has been interpreted as showing that inter- 
actions between the C-terminal helix and the N-terminal do- 
main have an essential role in mediating the conformational 
change during catalysis. 
It is therefore reasonable to conclude that the removal of 
the C-terminal lysine residue activates PGK by modifying the 
interactions of the C-terminal loop with the N-terminal do- 
main. Observation of the three-dimensional structure shows 
that this lysine, Lys-415, lies on the surface of the protein, 5.5 
A from glutamate-413. Glutamate-413 is also 6.5 A from ly- 
sine-5 (Fig. 2). The linear array of these three residues sug- 
gests that glutamate-413 can make interactions with both of 
these lysine residues. Removal of lysine-415 will therefore be 
expected to strengthen the interaction between lysine-5 and 
glutamate-413. Lysine-5 is part of the N-terminal sequence 
which folds over and contacts the C-terminal domain. 
Strengthening the interactions between these two inter-domain 
spanning regions appears to rigidify the hinge in the active 
orientation. The present results suggest that the C-terminal 
lysine acts as a sensitive moderator of the energy barrier to 
hinge bending, resulting in the native PGK having a specific 
activity that is less than it could otherwise have, if hinge 
bending were not an important feature of this enzyme. 
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